Philippines to require age and ID verification for online sales of nicotine products

Oct.26.2022
Philippines to require age and ID verification for online sales of nicotine products
The Philippines will require age and identity verification for online purchases of vapor nicotine and non-nicotine products.

The proposed implementing rules and regulations (IRR) of the Philippine regulations on vaporized nicotine and non-nicotine products will require age and identity verification for customers who order such products online.


According to a draft of the Implementing Rules and Regulations (IRR) released on the website of the Department of Trade and Industry (DTI) in the Philippines, e-commerce platforms, online markets, and electronic retailers must implement an "access restriction mechanism" for products approved by the DTI.


The draft law also requires that online sellers can only ship directly to buyers or authorized representatives who are at least 18 years old and verified through government-issued identification.


According to the draft, "If the authorized representative has not reached the legal age, the seller can re-deliver the product at the buyer's expense. For electronic commerce platforms, e-commerce platforms, and online retailers, the buyer cannot use the excuse of not knowing their true age or not knowing the buyer's real age as a defense. The buyer had no reason to believe or know that the product was intended for consumption by those under the age of 18, and even if the buyer and the representative provide proof of age, this does not constitute a defense.


These rules are aimed at ensuring that minors cannot access vaporized nicotine and non-nicotine products, their delivery devices, and new tobacco products.


The proposed IRR also mandates online sellers to register their company names with the DTI, SEC, or Cooperative Development Bureau. Additionally, the draft prohibits the sale of electronic cigarette products through phone or SMS sales. The draft specifies that "sellers should recommend buyers to do proper age verification in-store or in online stores.


The Department of Trade and Industry (DTI) announced that a virtual public consultation will be held on October 27 and October 28 regarding the draft proposal.


This draft will be implemented as an unnumbered joint administrative order to be released by the Department of Trade and Industry (DTI), Department of Health (DoH), Food and Drug Administration (FDA), and Bureau of Internal Revenue (BIR).


According to the proposed legislation, the Department of Health (DoH) has the authority to enforce Republic Act No. 10643 or the "Graphic Health Warning Law," while the Food and Drug Administration (FDA) oversees the registration of tobacco products and has the power to regulate products that make claims of therapeutic or medicinal benefits or risk reduction, with the exception of deceitful, unfair, and unreasonable sales practices.


The bill authorizes BIR to register industry participants for tax purposes, while DTI oversees compliance with product sales rules.


Various groups oppose the passing of the law, claiming that e-cigarette products pose a health risk to young people. The DTI believes that the risk can be reduced through product testing.


According to the Philippine Manufacturers Association, this law will protect consumers from the harm caused by counterfeit products.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only for industry communication and research purposes.


Due to limitations in the level of translation, the translated article may not fully represent the original text. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts held its second U.S. PMTA compliance training in Shenzhen, providing a systematic overview of the U.S. regulatory framework for e-cigarettes and corporate compliance strategies. Nearly 20 industry professionals from manufacturing, e-liquid and supply-chain companies attended. Participants who passed the exam received compliance certification. Registration for the third training session will open soon, alongside customized corporate training programs.
Mar.09
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia warns of a booming illicit vape market, raising risks for minors and legitimate trade
Estonia’s Chamber of Commerce and Industry and the Tax and Customs Board are urging the government to address a thriving illicit vape market that undermines fair competition and makes vapes easily accessible to minors.
Feb.04 by 2FIRSTS.ai
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan, Ph.D., has been named a 2026 Fellow of the Society for Research on Nicotine and Tobacco (SRNT), an international professional association dedicated to advancing nicotine and tobacco research. Fellows are selected for outstanding research contributions as well as leadership, mentoring, and policy engagement within the field.
Feb.23
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.
Mar.09